Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Segment Reporting Financial Information (Details)

v3.23.3
Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Revenues $ 29,473,949 $ 26,449,819 $ 87,081,953 $ 73,573,933
Depreciation and amortization 2,349,206 1,779,924 6,893,529 4,578,450
Segment operating income (loss) (898,047) 732,316 (1,925,711) (636,859)
Other income (expense), net (6,244) (25,235) 3,708,399 (60,668)
Income (loss) before income tax (benefit) expense (904,291) 707,081 1,782,688 (697,527)
Operating Segments        
Segment Reporting Information [Line Items]        
Segment operating income (loss) 4,207,640 5,135,536 12,581,520 11,952,420
Unallocated corporate        
Segment Reporting Information [Line Items]        
Segment operating income (loss) (5,105,687) (4,403,220) (14,507,231) (12,589,279)
Corporate clinics        
Segment Reporting Information [Line Items]        
Revenues 17,882,303 15,836,327 52,813,098 42,936,298
Corporate clinics | Operating Segments        
Segment Reporting Information [Line Items]        
Depreciation and amortization 2,067,803 1,504,914 6,027,561 3,780,283
Segment operating income (loss) (931,366) (60,022) (1,331,630) 345,657
Franchise operations        
Segment Reporting Information [Line Items]        
Revenues 11,591,646 10,613,492 34,268,855 30,637,635
Franchise operations | Operating Segments        
Segment Reporting Information [Line Items]        
Depreciation and amortization 190,867 189,426 597,557 549,161
Segment operating income (loss) 5,139,006 5,195,558 13,913,150 11,606,763
Corporate administration        
Segment Reporting Information [Line Items]        
Depreciation and amortization $ 90,536 $ 85,584 $ 268,411 $ 249,006